StonvexLoading…
StonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | LH Labcorp Holdings | $254.02 | -0.16% | $20.8B | 22.1 | 1.5 | +7.3% | 28.8% | 45 |
| 1 | LLY Eli Lilly | $1006.70 | -0.89% | $944.5B | 37.4 | 13.1 | +47.4% | 82.8% | 52 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $24.24 |
| +0.41% |
| $5.5B |
| 42.9 |
| 2.3 |
| +59.0% |
| 73.8% |
| 50 |
| 3 | CVS CVS Health | $97.15 | -0.98% | $124.2B | 42.4 | 0.3 | +7.6% | 13.9% | 49 |
| 4 | DVA DaVita | $192.58 | -2.79% | $12.4B | 15.9 | 0.9 | +6.7% | 32.5% | 49 |
| 5 | CI Cigna | $294.93 | -1.92% | $78.8B | 12.5 | 0.3 | +8.8% | 9.2% | 48 |
| 6 | DGX Quest Diagnostics | $187.94 | -1.52% | $20.9B | 20.4 | 1.9 | +11.0% | 33.3% | 45 |
| 7 | GH Guardant Health | $98.66 | +0.19% | $13.1B | — | 12.1 | +39.6% | 64.9% | 45 |
| 8 | BTSG BTSG | $58.40 | +3.36% | $11.3B | 36.5 | 0.8 | +18.0% | 12.2% | — |
| 9 | CHE CHE | $426.21 | +0.51% | $5.7B | 21.9 | 2.2 | +2.1% | 32.4% | — |